Drug recommendation method and computer program product

By displaying the test results and drug combination list in home medical scenarios, and determining drugs based on user information and geographical location, the problem of cumbersome process of users to obtain drugs is solved, and efficient and reasonable delivery of drugs is achieved.

CN118982408AInactive Publication Date: 2024-11-19BEIJING SANKUAI ONLINE TECH CO LTD

Patent Information

Application Number
CN202411045256.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-31
Publication Date
2024-11-19
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the home medical scenario, the process of obtaining drugs by users is cumbersome, difficult to improve efficiency and insufficient rationality.

Method used

By responding to the operation of viewing online test reports, display the test results and drug combination list, determine the drugs to be selected based on the test results, user complaint symptoms, user information and geographical location, and provide delivery within the preset time to simplify selection and ordering process.

Benefits of technology

It greatly improves the efficiency of users to obtain drugs and ensures the rationality and timely delivery of drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118982408A_ABST
    Figure CN118982408A_ABST
Patent Text Reader

Abstract

The invention provides a drug recommendation method and a computer program product. The method comprises the steps that in response to an operation of checking an online detection report, a detection result corresponding to the online detection report, a medicine combination list and an ordering interaction control are displayed, and the medicine combination list comprises medicine information corresponding to one or more to-be-selected medicines and a medicine selection control; the to-be-selected medicine is determined according to the detection result, the user chief complaint symptom, the user information and the user terminal position, and the delivery duration between the delivery position corresponding to the to-be-selected medicine and the user terminal position is smaller than or equal to the preset duration; in response to selection of the drug selection control, marking selected drugs in the to-be-selected drugs, and updating a settlement amount corresponding to the ordering interaction control according to the selected drugs; and responding to a preset operation on the ordering interaction control, generating a take-out order corresponding to the selected medicine, and displaying a take-out order settlement page corresponding to the take-out order. According to the embodiment of the invention, the medicine obtaining efficiency of a user in an online medical scene can be improved.
Need to check novelty before this filing date? Find Prior Art

Description

Background Art

[0002] With the development of medical technology, door-to-door testing services exist, allowing users to receive medical examinations at home, which not only facilitates users but also reduces the burden on primary medical institutions, allowing minor illnesses and chronic diseases to be discovered in a timely manner.

[0003] However, after the examination, it is usually necessary to prescribe and purchase medicines, and users need to perform cumbersome operations to obtain the medicines. Therefore, it is necessary to further provide convenience for users.

[0004] It should be noted that the information disclosed in the above background technology section is only used to enhance the understanding of the background of the present disclosure, and therefore may include information that does not constitute the prior art known to ordinary technicians in the field. Summary of the invention

[0005] The purpose of the present disclosure is to provide a drug recommendation method and a computer program product for improving the efficiency of users in obtaining drugs in home medical scenarios.

[0006] According to a first aspect of an embodiment of the present disclosure, a drug recommendation method is provided, comprising: in response to an operation of viewing an online test report, displaying a test result corresponding to the online test report, a drug combination list, and an order interaction control, the drug combination list including drug information and a drug selection control corresponding to one or more drugs to be selected, the drugs to be selected are determined based on the test results, the user's main symptoms, user information, and the user's terminal location, and the delivery time between the delivery location corresponding to the drugs to be selected and the user's terminal location is less than or equal to a preset time; in response to a selection of the drug selection control, marking the selected drugs among the drugs to be selected, and updating the settlement amount corresponding to the order interaction control according to the selected drugs; in response to a preset operation on the order interaction control, generating a takeaway order corresponding to the selected drugs, and displaying a takeaway order settlement page corresponding to the takeaway order.

[0007] In an exemplary embodiment of the present disclosure, it also includes: when the selected drugs include prescription drugs, displaying a prescription viewing entrance corresponding to the prescription drugs; and displaying the prescription in response to a triggering operation on the prescription viewing entrance.

[0008] In an exemplary embodiment of the present disclosure, displaying the test results, drug combination list and order interaction controls corresponding to the online test report includes: determining abnormal detection indicators among multiple preset detection indicators based on the test report; determining one or more drugs to be selected and the quantity of each drug to be selected based on the user's main symptoms, abnormal detection indicators, and user information.

[0009] In an exemplary embodiment of the present disclosure, determining one or more candidate drugs and the quantity of each candidate drug according to the user's main symptoms, abnormality detection indicators, and user information includes: determining one or more alternative drugs corresponding to each user's main symptoms and each abnormality detection indicator and the quantity of each alternative drug; after deduplication operation on one or more alternative drugs, forming an alternative drug list including multiple alternative drugs according to the user information; according to the components of the alternative drugs in the alternative drug list, determining multiple first alternative drugs with mutually exclusive components and multiple second alternative drugs with overlapping components, and determining the alternative drugs in the alternative drug list except the first alternative drug and the second alternative drug as the third alternative drug; deleting one or more first alternative drugs from the multiple first alternative drugs based on the mutually exclusive components, and deleting one or more second alternative drugs from the multiple second alternative drugs based on the overlapping components; determining one or more candidate drugs and the quantity of each candidate drug based on the first alternative drug, the second alternative drug, and the third alternative drug.

[0010] In an exemplary embodiment of the present disclosure, deleting one or more first candidate drugs from multiple first candidate drugs based on a mutually exclusive relationship of components, and deleting one or more second candidate drugs from multiple second candidate drugs based on a coincidence relationship of components include: determining the first priority of each main complaint symptom, wherein the severity of the user's main complaint symptom with a high first priority is high; determining the first priority of the user's main complaint symptom corresponding to each first candidate drug; among any two first candidate drugs with a mutually exclusive relationship of components, deleting the first candidate drugs with a lower first priority of the corresponding user's main complaint symptom; determining the second priority of each abnormality detection indicator, wherein the degree of abnormality of the abnormality detection indicator with a high second priority is high; determining the second priority of the abnormality detection indicator corresponding to each second candidate drug; and among any two second candidate drugs with a coincidence relationship of components, deleting the second candidate drugs with a lower second priority of the corresponding abnormality detection indicator.

[0011] In an exemplary embodiment of the present disclosure, forming an alternative drug list including multiple alternative drugs based on user information includes: determining the applicable age and contraindications corresponding to each alternative drug, the contraindication information including at least allergy information; determining the user's age information and contraindication information based on the user information; among the multiple alternative drugs, deleting the alternative drugs whose applicable age does not match the user's age information and the alternative drugs whose contraindications match the user's contraindication information, and generating an alternative drug list based on the remaining alternative drugs.

[0012] In an exemplary embodiment of the present disclosure, determining one or more alternative drugs and the quantity of each alternative drug based on the first alternative drug, the second alternative drug, and the third alternative drug includes: determining at least one of the first alternative drug, the second alternative drug, and the third alternative drug corresponding to a main complaint symptom as a fourth alternative drug corresponding to the main complaint symptom; obtaining the degree of compatibility of each fourth alternative drug with the main complaint symptom, determining the fourth alternative drug with the highest degree of compatibility as the alternative drug corresponding to the main complaint symptom, and determining the number of alternative drugs according to the first priority of the main complaint symptom; determining at least one of the first alternative drug, the second alternative drug, and the third alternative drug corresponding to an abnormality detection indicator as a fifth alternative drug corresponding to the main complaint symptom; obtaining the degree of compatibility of each fifth alternative drug with the abnormality detection indicator, determining the fifth alternative drug with the highest degree of compatibility as the alternative drug corresponding to the abnormality detection indicator, and determining the number of alternative drugs according to the second priority of the abnormality detection indicator.

[0013] According to a second aspect of an embodiment of the present disclosure, a drug recommendation device is provided, including: a drug display module, configured to respond to the operation of viewing an online test report, display the test results corresponding to the online test report, a drug combination list and an order interaction control, the drug combination list including drug information and a drug selection control corresponding to one or more drugs to be selected, the drugs to be selected are determined based on the test results, the user's main symptoms, user information and the user's terminal location, and the delivery time between the delivery location corresponding to the drug to be selected and the user's terminal location is less than or equal to a preset time; a drug selection module, configured to respond to the selection of the drug selection control, mark the selected drugs among the drugs to be selected, and update the settlement amount corresponding to the order interaction control according to the selected drugs; a drug delivery module, configured to respond to the preset operation of the order interaction control, generate a takeaway order corresponding to the selected drug, and display the takeaway order settlement page corresponding to the takeaway order.

[0014] According to a third aspect of the present disclosure, there is provided an electronic device, comprising: a memory; and a processor coupled to the memory, wherein the processor is configured to execute any one of the methods described above based on instructions stored in the memory.

[0015] According to a fourth aspect of the present disclosure, there is provided a computer-readable storage medium having a program stored thereon, which, when executed by a processor, implements the drug recommendation method as described in any one of the above.

[0016] According to a fifth aspect of the present disclosure, a computer program product is provided, comprising a computer program, which implements the steps of any of the above methods when executed by a processor.

[0017] The disclosed embodiment determines a drug combination list and an ordering interactive control according to the user's geographic location and user information when the user views the test report, so that the user can obtain suitable drugs within a preset delivery time through two simple operations of selection and ordering, thereby greatly improving the efficiency of users in obtaining drugs in online medical scenarios and ensuring the rationality of the drugs obtained by the user.

[0018] It is to be understood that the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the present disclosure. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] The accompanying drawings herein are incorporated into the specification and constitute a part of the specification, illustrate embodiments consistent with the present disclosure, and together with the specification are used to explain the principles of the present disclosure. Obviously, the accompanying drawings described below are only some embodiments of the present disclosure, and for ordinary technicians in this field, other accompanying drawings can be obtained based on these accompanying drawings without creative work.

[0020] Figure 1 is a flow chart of a drug recommendation method in an exemplary embodiment of the present disclosure.

[0021] Figure 2 is a schematic diagram of an interface presented in an exemplary embodiment of the present disclosure.

[0022] Figure 3A and Figure 3B It is a schematic diagram showing a medical advice document in an exemplary embodiment of the present disclosure.

[0023] Figure 4 It is a schematic diagram of an interface for obtaining protective equipment in an exemplary embodiment of the present disclosure.

[0024] Figure 5 It is a schematic diagram of an interface of prescription drugs in an exemplary embodiment of the present disclosure.

[0025] Figure 6 It is a schematic diagram of an interface for obtaining user's main symptoms in an exemplary embodiment of the present disclosure.

[0026] Figure 7 Detailed description is a flowchart of a process of determining a drug to be selected in an exemplary embodiment of the present disclosure.

[0027] Figure 8 It is a sub-flowchart of step S72 in the exemplary embodiment of the present disclosure.

[0028] Fig. 9 It is a sub-flowchart of step S725 in the exemplary embodiment of the present disclosure.

[0029] Fig.10This is a flow chart of selecting drugs to be selected based on the user terminal location in an embodiment of the present disclosure.

[0030] Fig.11 It is a sub-flowchart of step S102 in the exemplary embodiment of the present disclosure.

[0031] Fig.12 is a schematic diagram of an implementation of method 100 in an application scenario.

[0032] Fig.13 is a block diagram of an electronic device in an exemplary embodiment of the present disclosure. DETAILED DESCRIPTION

[0033] Example embodiments will now be described more fully with reference to the accompanying drawings. However, example embodiments can be implemented in a variety of forms and should not be construed as being limited to the examples set forth herein; on the contrary, these embodiments are provided so that the present disclosure will be more comprehensive and complete, and the concepts of the example embodiments are fully conveyed to those skilled in the art. The described features, structures, or characteristics may be combined in one or more embodiments in any suitable manner. In the following description, many specific details are provided to provide a full understanding of the embodiments of the present disclosure. However, those skilled in the art will appreciate that the technical solutions of the present disclosure may be practiced while omitting one or more of the specific details, or other methods, components, devices, steps, etc. may be adopted. In other cases, known technical solutions are not shown or described in detail to avoid obscuring various aspects of the present disclosure.

[0034] In addition, the accompanying drawings are only schematic diagrams of the present disclosure, and the same reference numerals in the drawings represent the same or similar parts, so their repeated description will be omitted. Some of the block diagrams shown in the accompanying drawings are functional entities, which do not necessarily correspond to physically or logically independent entities. These functional entities can be implemented in software form, or implemented in one or more hardware modules or integrated circuits, or implemented in different networks and / or processor devices and / or microcontroller devices.

[0035] The exemplary embodiments of the present disclosure are described in detail below with reference to the accompanying drawings.

[0036] Figure 1 is a flow chart of a drug recommendation method in an exemplary embodiment of the present disclosure.

[0037] refer to Figure 1 , the drug recommendation method 100 may include:

[0038] Step S1, in response to the operation of viewing the online test report, displaying the test results corresponding to the online test report, a drug combination list, and an order interaction control, wherein the drug combination list includes drug information and a drug selection control corresponding to one or more drugs to be selected, wherein the drugs to be selected are determined according to the test results, the user's main symptoms, user information, and the user's terminal location, and the delivery time between the delivery location corresponding to the drug to be selected and the user's terminal location is less than or equal to a preset time;

[0039] Step S2, in response to the selection of the drug selection control, marking the selected drug among the drugs to be selected, and updating the settlement amount corresponding to the order interaction control according to the selected drug;

[0040] Step S3, in response to the preset operation of the order interaction control, generating a takeaway order corresponding to the selected medicine, and displaying a takeaway order settlement page corresponding to the takeaway order.

[0041] The disclosed embodiment determines a drug combination list and an ordering interactive control according to the user's geographic location and user information when the user views the test report, so that the user can obtain suitable drugs within a preset delivery time through two simple operations of selection and ordering, thereby greatly improving the efficiency of users in obtaining drugs in online medical scenarios and ensuring the rationality of the drugs obtained by the user.

[0042] Next, the drug recommendation method 100 is described in detail.

[0043] In step S1, in response to the operation of viewing the online test report, the test results, drug combination list and order interaction controls corresponding to the online test report are displayed, and the drug combination list includes drug information and drug selection controls corresponding to one or more selected drugs. The selected drugs are determined based on the test results, user's main symptoms, user information and user terminal location, and the delivery time between the delivery location corresponding to the selected drugs and the user terminal location is less than or equal to the preset time.

[0044] The method of the embodiment of the present disclosure can be used to view online test reports after a user orders a home testing service, or to view online test reports provided by a hospital, or in other application scenarios where it is necessary to view online test reports, the test results can be uploaded by the testing agency or hospital after testing.

[0045] In an exemplary embodiment, the user places an order to purchase the testing service, and the deliveryman is responsible for delivering the disposable sampler to the user's order address. After the user takes the sample according to the instructions, the deliveryman will deliver it to a nearby testing agency or hospital for testing, and upload the test results to the system. Users can complete the sampling and obtain the test results quickly at home without leaving home, waiting in line, or fearing cross-infection. Testing services include but are not limited to respiratory testing, gynecological testing, allergy testing, gastrointestinal testing, etc.

[0046] In the disclosed embodiment, after determining that the test results have been uploaded, an online test report can be automatically generated, and the user can be guided to check the online test report in a timely manner through push messages or SMS reminders on the user APP or mini program side.

[0047] The user can view the online test report by clicking on a preset control, or performing a preset interactive operation with the control (such as face recognition, etc.), or directly calling up the function of viewing the online test report through a preset operation, such as using voice control to use the built-in artificial intelligence program in the mobile phone to view the online test report.

[0048] The medium for viewing the online test report can be a mobile terminal such as a mobile phone, a tablet computer, a laptop computer, or a fixed electronic device, such as a service machine (with an operation screen) fixed at a certain location in the community. As long as the method 100 provided by the present disclosure can be run, the present disclosure does not impose any special restrictions on this.

[0049] Method 100 may be invoked or called by a user viewing an online detection report.

[0050] After users view the online test report, they can display the test results, drug combination list and order interactive controls through various image display methods such as physical screens, VR scene views, holographic images, etc.

[0051] Figure 2 is a schematic diagram of an interface displayed in an exemplary embodiment of the present disclosure. Interface 200 is only described by taking screen display as an example, and those skilled in the art can refer to Figure 2 The illustrated embodiment expands the display mode to other image display means.

[0052] refer to Figure 2 In an exemplary embodiment, the interface 200 may include a test report 21, a drug combination list 22, and an order interaction control 23. The purpose of displaying the test result 21 is to respond to the user's operation intention and give feedback; the purpose of displaying the drug combination list 22 and the order interaction control 23 is to facilitate the user to obtain drugs. The selection logic of the drugs to be selected will be described in detail in subsequent embodiments, and this embodiment only introduces the interface display.

[0053] exist Figure 2 In the illustrated embodiment, the test report 21 may include: Figure 2 The user's name, age, gender and other basic information as well as the brief test results are shown on the left, as well as Figure 2 The detection details shown on the right side include, for example, detection results 211 of multiple detection items and a detection details viewing control 212 .

[0054] The drug combination list 22 may include drug information 221 such as drug name, drug quantity, drug price, etc. of multiple drugs to be selected, as well as a drug selection control 222, through which the user can select or not select the drugs to be selected.

[0055] The order interactive control 23 has a corresponding settlement amount display area 231. The settlement amount displayed in the settlement amount display area 231 is updated according to the user's operation on the drug selection control 222, and displays the total amount of the selected drugs (the drugs to be selected that the user has selected). In addition, the order interactive control 23 can also display information such as delivery time and delivery address.

[0056] Thus, in step S2, in response to the user's selection of the drug selection control 222, the selected drug in the to-be-selected drugs is marked, and the settlement amount displayed in the settlement amount display area 231 corresponding to the order interaction control 23 is updated according to the selected drug, such as Figure 1 shown.

[0057] The positional relationship between the test report 21, the drug combination list 22 and the order interactive control 23, as well as the corresponding relationship between the internal parts or the corresponding parts can be adjusted by those skilled in the art according to their needs and are not limited to Figure 2 The relative position relationship shown.

[0058] In step S3, in response to the preset operation of the order interaction control 23, a takeaway order corresponding to the selected medicine is generated, and a takeaway order settlement page corresponding to the takeaway order is displayed.

[0059] The preset operation may include, for example, clicking on the order interaction control 23. The takeaway order and the takeaway order settlement page may be formed according to general methods in the art, and the present disclosure does not impose any particular limitation on this.

[0060] The method 100 of the disclosed embodiment allows the user to select medicines and directly place an order to form a takeaway order by displaying the test results 21, the drug combination list 22 and the order interaction control 23 to the user when the user views the test report. Since the delivery time between the delivery location corresponding to the selected medicine and the user terminal location is less than or equal to the preset time, the user can obtain the medicine within the preset delivery time, which greatly improves the efficiency of the user in obtaining medicines.

[0061] In some embodiments, in addition to displaying the above-mentioned test report 21, drug combination list 22 and order interaction control 23 on the interface, medical advice can also be displayed.

[0062] Figure 3A and Figure 3B It is a schematic diagram showing a medical advice document in an exemplary embodiment of the present disclosure.

[0063] refer to Figure 3A In some embodiments, the medical advice document 24 can be displayed while displaying the test report 21, the drug combination list 22, and the order interaction control 23.

[0064] The medical advice document is generated based on the test results, the user's main symptoms, and the user information. The collection of the user's main symptoms is described in detail in the subsequent embodiments.

[0065] In addition, protection suggestions 25 and recuperation suggestions 26 can also be selectively displayed.

[0066] refer to Figure 3B In other embodiments, if the test indicators are normal, or if there are no symptoms, or if the user belongs to a special group (a history of drug allergy, chronic liver and kidney dysfunction, pregnant or breastfeeding, or a child under 2 years old), then drugs may not be provided to the user. After receiving the online test report, only the test results 21 and the medical advice copy 14 corresponding to the online test report are displayed, without displaying the drug combination list 22 and the order interaction control 23.

[0067] In addition, protection suggestions 25 and recuperation suggestions 26 can also be selectively displayed.

[0068] In some embodiments, the way to obtain protective equipment can also be displayed in the protection advice 25.

[0069] Figure 4 It is a schematic diagram of an interface for obtaining protective equipment in an exemplary embodiment of the present disclosure.

[0070] refer to Figure 4 ,exist Figure 3A or Figure 3B In the embodiment, the protection suggestion area 25 may include only the protection suggestion text 251, or may include both the protection suggestion text 251 and the protection supplies purchase area 252. The protection supplies may be automatically recommended by the system based on the protection suggestion text 251, or may be selected by the user.

[0071] Protective equipment can be wearable items such as masks, goggles, and gloves, or medical devices such as wheelchairs, crutches, and blood pressure monitors.

[0072] Users can jump to other interfaces to purchase protective items (including medical devices) and then return to Figure 4 In some embodiments, the ordering control may not be displayed in the protection suggestion 25 area, but the price of the protective equipment may be directly added to the ordering interactive control 23 corresponding to the drug combination list.

[0073] In addition to considering whether medicines and protective equipment are provided, when displaying the interface, you can also consider whether the medicine selected by the user is a prescription drug.

[0074] Figure 5 It is a schematic diagram of an interface of prescription drugs in an exemplary embodiment of the present disclosure.

[0075] refer to Figure 5 , when the selected drugs include prescription drugs, the prescription viewing entry 222 corresponding to the prescription drugs is displayed. In the background, when the drug combination list 22 is generated and it is determined that there are prescription drugs in the drugs to be selected, an electronic prescription can be automatically issued, and the prescription viewing entry 222 can be displayed on the interface; or, when the user operates the drug selection control and selects the selected drugs and the selected drugs include prescription drugs, an electronic prescription can be automatically issued, and the prescription viewing entry 222 can be displayed on the interface.

[0076] During the automatic prescription process, it can be determined based on the user information whether the user has completed the real-name authentication. If the user has not completed the real-name authentication, the real-name authentication page can be displayed; if the user has completed the real-name authentication, a prescription is automatically generated based on the test results, the user's main symptoms, and the user information, and the prescription viewing entrance 222 is displayed.

[0077] In the process of determining the drugs to be selected in the drug combination list, the above embodiments determine whether to prescribe drugs and which drugs (drugs to be selected) to prescribe based on the test results, user's main symptoms, user information and user terminal location. Therefore, before the user views the test report, in addition to automatically querying the test report corresponding to the user, a user information input method and a user's main symptoms acquisition method can also be provided. User information includes but is not limited to the user's name, age, gender, identifier, allergy history, past medical history, special physiological conditions (pregnancy), etc., which can be obtained by filling out a general form.

[0078] The user's main symptoms can be obtained by asking the user to fill out a form, fill in text information, enter voice information, etc., or through interface interactive controls.

[0079] Figure 6 It is a schematic diagram of an interface for obtaining user's main symptoms in an exemplary embodiment of the present disclosure.

[0080] refer to Figure 6, a display control 61 corresponding to common symptoms can be displayed for the user to select, so that the user can efficiently and accurately provide the user's main symptoms. Common symptoms include but are not limited to fever, cough, etc. The user can mark the selected common symptoms by selecting the display control 61.

[0081] In addition, an information acquisition area 62 may be displayed on the interface for the user to select other information to complete the user information. The information acquisition area 62 includes but is not limited to the use of anti-infective drugs before the test, close contact history, basic disease history, drug allergy history, etc.

[0082] After obtaining the test results, user's main symptoms, and user information, the user's terminal location can be automatically obtained through the device's background positioning, and then the screening of candidate drugs can be started to form a drug combination list.

[0083] Figure 7 Detailed description is a flowchart of a process of determining a drug to be selected in an exemplary embodiment of the present disclosure.

[0084] refer to Figure 7 In an exemplary embodiment, the process of determining a drug to be selected may include:

[0085] Step S71, determining an abnormal detection index among a plurality of preset detection indexes according to the detection report;

[0086] Step S72, determining one or more drugs to be selected and the quantity of each drug to be selected based on the user's main symptoms, abnormal detection indicators, and user information.

[0087] Step S71 can be implemented by automatically reading the test report. The preset test index may be different according to the test items ordered by the user, and the corresponding preset test index and the normal value range of each preset test index may be set in advance for each test item. For example, if the user orders a blood test, the preset test index may include the number of platelets, the number of white blood cells, the number of neutrophils, etc. corresponding to the blood test. After reading the test value corresponding to each preset test index, it is determined whether the preset test index of the user is an abnormal test index according to the normal value range of each preset test index, and if the test value exceeds the normal range, it is determined to be an abnormal test index.

[0088] Next, in step S72, the drugs to be selected may be first determined according to the symptoms of the user, and then further screened among the drugs to be selected according to the user terminal location.

[0089] Figure 8 It is a sub-flowchart of step S72 in the exemplary embodiment of the present disclosure.

[0090] refer to Figure 8 In an exemplary embodiment, step S72 may include:

[0091] Step S721, determining one or more candidate drugs corresponding to each user's main symptom and each abnormal detection index and the quantity of each candidate drug;

[0092] Step S722, after performing a deduplication operation on one or more candidate drugs, a candidate drug list including multiple candidate drugs is formed according to the user information;

[0093] Step S723, according to the ingredients of the candidate drugs in the candidate drug list, a plurality of first candidate drugs having mutually exclusive ingredients and a plurality of second candidate drugs having overlapping ingredients are determined, and the candidate drugs in the candidate drug list other than the first candidate drug and the second candidate drug are determined as third candidate drugs;

[0094] Step S724, deleting one or more first candidate drugs from the plurality of first candidate drugs based on the mutually exclusive relationship of the components, and deleting one or more second candidate drugs from the plurality of second candidate drugs based on the overlapping relationship of the components;

[0095] Step S725, determining one or more drugs to be selected and the quantity of each drug to be selected based on the first candidate drug, the second candidate drug, and the third candidate drug.

[0096] The corresponding alternative medicine and the quantity of each alternative medicine can be set in advance for each symptom, the corresponding alternative medicine can be set for each preset detection index, and the quantity of each alternative medicine corresponding to different detection values ​​can be set. Therefore, after obtaining the user's main symptoms and abnormal detection indicators, the alternative medicine and the quantity of alternative medicine can be directly determined.

[0097] Next, a deduplication operation is performed. In an exemplary embodiment, the deduplication operation for one or more candidate drugs in step S722 includes: obtaining the generic name and drug brand of each candidate drug, determining the dynamic evaluation level corresponding to the drug brand of each candidate drug among the candidate drugs with overlapping generic names, and retaining only the candidate drugs with the highest dynamic evaluation level corresponding to the drug brand among the candidate drugs with overlapping generic names. The dynamic evaluation level is updated regularly according to user feedback.

[0098] The deduplication operation is first performed based on the generic name of the drug. For example, the generic name of many cold medicines is paracetamol, and the generic name of many antipyretic drugs is acetaminophen, but different manufacturers have different names. Therefore, we can first find alternative drugs with the same generic name, and select the drugs with the best user feedback (that is, the highest dynamic evaluation level) and include them in the list of alternative drugs. Through the deduplication operation, users can avoid purchasing drugs with duplicate efficacy.

[0099] Next, in steps S723 to S725, among the alternative drugs after deduplication, only one is selected from the drugs with mutually exclusive efficacy to avoid medication accidents; only one is selected from the drugs with overlapping ingredients to avoid overdose. In some embodiments, only one can be selected from the drugs with overlapping efficacy (for example, acetaminophen or ibuprofen can be selected as an antipyretic, but the two should not be selected repeatedly).

[0100] In an exemplary embodiment, in step S724, the first priority of each main complaint symptom can be first determined, and the severity of the user's main complaint symptom with a high first priority is high. Then, the first priority of the user's main complaint symptom corresponding to each first alternative drug is determined. Among any two first alternative drugs with mutually exclusive components, the first alternative drugs with lower first priority of the corresponding user's main complaint symptoms are deleted.

[0101] Next, the second priority of each abnormality detection indicator is determined. The abnormality detection indicator with a high second priority has a high degree of abnormality. Then the second priority of the abnormality detection indicator corresponding to each second candidate drug is determined. Among any two second candidate drugs with overlapping components, the second candidate drugs with lower second priority of the corresponding abnormality detection indicator are deleted.

[0102] Symptoms and abnormal detection indicators corresponding to each drug can be preset. For example, acetaminophen corresponds to fever, muscle pain, and increased white blood cell count, and cefixime dispersible tablets correspond to increased white blood cell count and excessive C-reactive protein.

[0103] In addition to the above embodiments, when selecting mutually exclusive drugs, the drugs to be retained can also be determined based on the severity of the abnormal detection index, and the drugs corresponding to the detection index with a more serious abnormality can be retained, or the drugs to be retained can be determined based on the user's main symptoms or the comprehensive severity of the abnormal detection index (for example, determined based on the weighted sum of the first priority or the second priority), and the corresponding drugs with a more serious comprehensive severity can be retained. Then, the drugs that are mutually exclusive with the retained drugs are deleted. The specific method of determining the severity can be found in the above embodiments, which will not be repeated here.

[0104] When selecting from drugs with overlapping ingredients, the drugs to be retained can also be determined based on the severity of the abnormal detection index, and the drugs corresponding to the detection index with a more serious abnormality can be retained, or the drugs to be retained can be determined based on the user's main symptoms or the comprehensive severity of the abnormal detection index (for example, determined based on the weighted sum of the first priority or the second priority), and the corresponding drugs with a more serious comprehensive severity can be retained. Then, the drugs with overlapping ingredients with the retained drugs are deleted.

[0105] In addition to operations such as deduplication, elimination of mutual exclusion, and elimination of overlap, the backup drugs can also be screened based on the user's specific circumstances, i.e., user information.

[0106] In an exemplary embodiment, the applicable age and contraindications corresponding to each candidate drug can be determined, and the contraindication information includes at least allergy information. Then, the user's age information and contraindication information are determined based on the user information. Finally, among multiple candidate drugs, the candidate drugs whose applicable age does not match the user's age information and the candidate drugs whose contraindications match the user's contraindication information are deleted, and a candidate drug list is generated based on the remaining candidate drugs. For example, if the user is under 12 years old, adult drugs can be deleted, if the user is over 18 years old, children's drugs can be deleted; if the user is allergic to cephalosporins, cephalosporin drugs can be deleted.

[0107] Screening according to the specific circumstances of the user can occur after removing duplicates from the backup drugs and before removing mutually exclusive and overlapping drugs, thereby reducing mutually exclusive and overlapping drugs and avoiding the situation where the drugs after removing mutually exclusive and overlapping drugs cannot meet the specific circumstances of the user.

[0108] After performing the above-mentioned deletion operation on the backup drugs, the remaining backup drugs can be further screened according to their therapeutic strength (or compatibility with symptoms or abnormality detection indicators).

[0109] Fig. 9 It is a sub-flowchart of step S725 in the exemplary embodiment of the present disclosure.

[0110] refer to Fig. 9 In an exemplary embodiment, step S725 may include:

[0111] Step S7251, determining at least one of the first candidate drug, the second candidate drug, and the third candidate drug corresponding to a main complaint symptom as a fourth candidate drug corresponding to the main complaint symptom;

[0112] Step S7252, obtaining the compatibility of each fourth candidate drug with the main complaint, determining the fourth candidate drug with the highest compatibility as the candidate drug corresponding to the main complaint, and determining the number of candidates according to the first priority of the main complaint;

[0113] Step S7253, determining at least one of the first candidate drug, the second candidate drug, and the third candidate drug corresponding to an abnormal detection indicator as a fifth candidate drug corresponding to the main complaint symptom;

[0114] Step S7254, obtain the degree of compatibility between each fifth candidate drug and the anomaly detection index, determine the fifth candidate drug with the highest degree of compatibility as the candidate drug corresponding to the anomaly detection index, and determine the number of candidate drugs according to the second priority of the anomaly detection index.

[0115] exist Fig. 9 In the illustrated embodiment, the candidate drugs can be screened according to the fitness of the candidate drugs and the main complaint symptoms, and the fitness of the abnormal detection index. The fitness of each drug for each symptom can be preset, for example, for the symptom of sore throat, the fitness of acetaminophen is less than that of watermelon frost lozenges, and for the symptom of cough, the fitness of acetaminophen is less than that of Chuanbei loquat paste. The fitness of each drug for each detection index can also be preset, for example, for the leukocyte index, the fitness of cephalosporin drugs is greater than that of acetaminophen.

[0116] Next, determine the quantity of medicines based on the severity of the symptoms or the degree of abnormality of the abnormal detection index (for example, the percentage exceeding the normal range). The specifications of the medicines need to be considered when determining the quantity of medicines. For example, if the detection value of C-reactive protein is 53, it is calculated that 100 mg of cephalosporin is needed. The cefixime dispersible tablets of manufacturer A contain 100 mg of cephalosporin, and the cefixime dispersible tablets of manufacturer B contain 50 mg of cephalosporin. If the medicine of manufacturer A is finally selected, the quantity of medicines is one box. If the medicine of manufacturer B is selected, the quantity of medicines is 2 boxes.

[0117] After determining the symptomatic medication, i.e., the drugs to be selected, based on the user's main symptoms, test indicators, and user information, it is necessary to further screen the drugs among the candidates based on the supply of the drugs.

[0118] Fig.10 This is a flow chart of selecting drugs to be selected based on the user terminal location in an embodiment of the present disclosure.

[0119] refer to Fig.10 In an exemplary embodiment, selecting a drug to be selected according to the user terminal location may include:

[0120] Step S101, determining inventory information of multiple merchants within a preset range of the user terminal location, which are in business and can deliver goods, and whose delivery time to the user terminal location is less than or equal to a preset time;

[0121] Step S102, determining nearby merchants from among multiple merchants whose inventory information matches the drugs to be selected in the drug combination list.

[0122] The preset range can be either a preset range of the straight-line distance from the user terminal location (e.g., within 5 km of the straight-line distance) or a preset range of the traffic distance (e.g., 1 km of the straight-line distance, 2.4 km of the electric vehicle riding route). The business status and delivery status can be determined by reading the information set by the merchant, and the delivery time can be automatically determined based on the merchant's location.

[0123] exist Fig.10In the illustrated embodiment, one can first select merchants whose delivery time meets the requirements, are in business and can deliver, and then select merchants whose inventory meets the requirements among these merchants, or one can first select merchants whose inventory meets the requirements, and then select merchants whose delivery time meets the requirements, are in business and can deliver among these merchants. In the latter case, a compromise can be made in terms of delivery time (merchants whose delivery time exceeds the preset time are allowed to appear) to better meet the demand for medicines.

[0124] Fig.11 It is a sub-flowchart of step S102 in the exemplary embodiment of the present disclosure.

[0125] refer to Fig.11 In an exemplary embodiment, step S102 may include:

[0126] Step S1021, based on the inventory information of multiple merchants, determine one or more merchants to be selected whose inventory drugs include all the drugs to be selected and whose quantity of inventory drugs is greater than or equal to the quantity of drugs to be selected;

[0127] Step S1022, when the number of merchants to be selected is greater than one, determining the purchase cost of medicines for each merchant to be selected based on all the medicines to be selected, and the starting price of each merchant to be selected;

[0128] Step S1023, deleting the merchants to be selected whose drug purchase costs are lower than the starting price;

[0129] Step S1024, among the remaining merchants to be selected, determining the delivery fee for purchasing medicines based on all the medicines to be selected for each merchant to be selected according to the user terminal location;

[0130] Step S1025, determine the N merchants for selection with the smallest sum of delivery cost and drug purchase cost as nearby merchants for purchase that match the drug for selection, N≥1.

[0131] exist Fig.11 In the illustrated embodiment, it is necessary not only to screen out merchants whose inventory meets the needs of all drugs to be selected, but also to determine the suppliers of the drugs to be selected based on price information such as drug purchase costs, minimum delivery prices, and delivery costs, so as to provide users with more feasible delivery plans and further optimize the user experience.

[0132] After determining the nearby merchants where the drug can be purchased, the nearby merchants where the sum of the delivery cost and the drug purchase cost is the smallest may be displayed, or N nearby merchants where the drug can be purchased may be displayed at the same time for the user to choose from.

[0133] Fig.12 is a schematic diagram of an implementation of method 100 in an application scenario. Fig.12 The application scenario shown includes front-end and back-end processing.

[0134] refer to Fig.12 In an exemplary embodiment, the user's testing and drug purchase process may include:

[0135] Step S1201, responding to the laboratory test report upload message, automatically obtaining the online test report and determining the test result;

[0136] Step S1202: If no abnormal test indicators appear in the online test report, then proceed to step S1213 without prescribing medicine, and then respond to the user's operation of viewing the online test report, displaying the test results and medical advice; otherwise, proceed to step S1203;

[0137] Step S1203, when it is determined that the user is a person for whom medication is not recommended, the process goes to step S1213, and no medication is prescribed. Subsequently, the user is responded to for viewing the online test report, and the test results and medical advice are displayed; for example, people for whom medication is not recommended include those with a history of drug allergy, chronic liver and kidney dysfunction, pregnant women and breastfeeding women, and children under 2 years old;

[0138] Step S1204, determining drugs to be selected according to the user's main symptoms, test results, and user information;

[0139] Step S1205: if the drugs to be selected include prescription drugs, then proceed to step S1206; if the drugs to be selected do not include prescription drugs, then proceed to step S1208;

[0140] Step S1206, obtaining user real-name authentication information;

[0141] Step S1207, the prescription drug prescribing information is exchanged according to the user's real-name authentication information, and after the prescription is successfully issued, step S1208 is entered; in this process, if the prescription is rejected or expired, a user prompt message needs to be generated, and the user is reminded to apply for a new prescription when viewing the interface;

[0142] Step S1208, in response to the user's operation of viewing the online test report, obtaining the user terminal location;

[0143] Step S1209, further screening the drugs to be selected according to the user terminal location to determine a drug combination list;

[0144] Step S1210, displaying the test report, drug combination list, and order interaction controls;

[0145] Step S1211, adjusting the amount corresponding to the order interaction control in response to the user's drug selection operation;

[0146] Step S1212, generating a takeaway order in response to the user's operation on the order interactive control, and displaying the takeaway order settlement page.

[0147] The disclosed embodiments can enable users to purchase medicines immediately after viewing the test report results, and can provide an efficient and convenient channel for purchasing medicines in the event of a public health emergency, thereby greatly optimizing the user experience.

[0148] In an exemplary embodiment of the present disclosure, an electronic device capable of implementing the above method is also provided.

[0149] It will be appreciated by those skilled in the art that various aspects of the present invention may be implemented as a system, method or program product. Therefore, various aspects of the present invention may be specifically implemented in the following forms, namely: a complete hardware implementation, a complete software implementation (including firmware, microcode, etc.), or a combination of hardware and software, which may be collectively referred to herein as a "circuit", "module" or "system".

[0150] Refer to the following Fig.13 An electronic device 1300 according to this embodiment of the present invention is described. Fig.13 The electronic device 1300 shown is only an example and should not bring any limitation to the functions and scope of use of the embodiments of the present invention.

[0151] like Fig.13 As shown, the electronic device 1300 is in the form of a general computing device. The components of the electronic device 1300 may include but are not limited to: at least one processing unit 1310, at least one storage unit 1320, and a bus 1330 connecting different system components (including the storage unit 1320 and the processing unit 1310).

[0152] The storage unit stores program codes, which can be executed by the processing unit 1310, so that the processing unit 1310 performs the steps according to various exemplary embodiments of the present invention described in the above “Exemplary Method” section of this specification. For example, the processing unit 1310 can perform the method shown in the embodiment of the present disclosure.

[0153] The storage unit 1320 may include a readable medium in the form of a volatile storage unit, such as a random access storage unit (RAM) 13201 and / or a cache storage unit 13202 , and may further include a read-only storage unit (ROM) 13203 .

[0154] The storage unit 1320 may also include a program / utility 13204 having a set (at least one) of program modules 13205, such program modules 13205 including but not limited to: an operating system, one or more application programs, other program modules, and program data, each of which or some combination may include an implementation of a network environment.

[0155] Bus 1330 may represent one or more of several types of bus structures, including a memory unit bus or memory unit controller, a peripheral bus, an accelerated graphics port, a processing unit, or a local bus using any of a variety of bus architectures.

[0156] The electronic device 1300 may also communicate with one or more external devices 1400 (e.g., keyboards, pointing devices, Bluetooth devices, etc.), may also communicate with one or more devices that enable a user to interact with the electronic device 1300, and / or communicate with any device that enables the electronic device 1300 to communicate with one or more other computing devices (e.g., routers, modems, etc.). Such communication may be performed via an input / output (I / O) interface 1350. Furthermore, the electronic device 1300 may also communicate with one or more networks (e.g., local area networks (LANs), wide area networks (WANs), and / or public networks, such as the Internet) via a network adapter 1360. As shown, the network adapter 1360 communicates with other modules of the electronic device 1300 via a bus 1330. It should be understood that, although not shown in the figure, other hardware and / or software modules may be used in conjunction with the electronic device 1300, including but not limited to: microcode, device drivers, redundant processing units, external disk drive arrays, RAID systems, tape drives, and data backup storage systems.

[0157] In addition, the electronic device 1300 may also be any type of electronic device such as a mobile phone, a smart watch, a smart bracelet, a smart transportation tool (such as a car), etc., and the present disclosure does not impose any special restrictions on this.

[0158] Through the description of the above implementation, it is easy for those skilled in the art to understand that the example implementation described here can be implemented by software, or by software combined with necessary hardware. Therefore, the technical solution according to the implementation of the present disclosure can be embodied in the form of a software product, which can be stored in a non-volatile storage medium (which can be a CD-ROM, a USB flash drive, a mobile hard disk, etc.) or on a network, including several instructions to enable a computing device (which can be a personal computer, a server, a terminal device, or a network device, etc.) to execute the method according to the implementation of the present disclosure.

[0159] In an exemplary embodiment of the present disclosure, a computer-readable storage medium is also provided, on which a program product capable of implementing the above method of the present specification is stored. In some possible implementations, various aspects of the present invention can also be implemented in the form of a program product, which includes a program code, and when the program product is run on a terminal device, the program code is used to enable the terminal device to execute the steps according to various exemplary embodiments of the present invention described in the above "Exemplary Method" section of the present specification.

[0160] The program product for implementing the above method according to an embodiment of the present invention can adopt a portable compact disk read-only memory (CD-ROM) and include program code, and can be run on a terminal device, such as a personal computer. However, the program product of the present invention is not limited thereto, and in this document, a readable storage medium can be any tangible medium containing or storing a program, which can be used by or in combination with an instruction execution system, an apparatus or a device.

[0161] The program product may use any combination of one or more readable media. The readable medium may be a readable signal medium or a readable storage medium. The readable storage medium may be, for example, but not limited to, an electrical, magnetic, optical, electromagnetic, infrared, or semiconductor system, device or device, or any combination of the above. More specific examples (non-exhaustive list) of readable storage media include: an electrical connection with one or more wires, a portable disk, a hard disk, a random access memory (RAM), a read-only memory (ROM), an erasable programmable read-only memory (EPROM or flash memory), an optical fiber, a portable compact disk read-only memory (CD-ROM), an optical storage device, a magnetic storage device, or any suitable combination of the above.

[0162] Computer readable signal media may include data signals propagated in baseband or as part of a carrier wave, in which readable program code is carried. Such propagated data signals may take a variety of forms, including but not limited to electromagnetic signals, optical signals, or any suitable combination of the above. Readable signal media may also be any readable medium other than a readable storage medium, which may send, propagate, or transmit a program for use by or in conjunction with an instruction execution system, apparatus, or device.

[0163] The program code embodied on the readable medium may be transmitted using any appropriate medium, including but not limited to wireless, wired, optical cable, RF, etc., or any suitable combination of the foregoing.

[0164] Program code for performing the operations of the present invention may be written in any combination of one or more programming languages, including object-oriented programming languages ​​such as Java, C++, etc., and conventional procedural programming languages ​​such as "C" or similar programming languages. The program code may be executed entirely on the user computing device, partially on the user device, as a separate software package, partially on the user computing device and partially on a remote computing device, or entirely on a remote computing device or server. In cases involving a remote computing device, the remote computing device may be connected to the user computing device through any type of network, including a local area network (LAN) or a wide area network (WAN), or may be connected to an external computing device (e.g., through the Internet using an Internet service provider).

[0165] In addition, the above-mentioned figures are only schematic illustrations of the processes included in the method according to an exemplary embodiment of the present invention, and are not intended to be limiting. It is easy to understand that the processes shown in the above-mentioned figures do not indicate or limit the time sequence of these processes. In addition, it is also easy to understand that these processes can be performed synchronously or asynchronously, for example, in multiple modules.

[0166] Those skilled in the art will readily appreciate other embodiments of the present disclosure after considering the specification and practicing the invention disclosed herein. This application is intended to cover any variations, uses, or adaptations of the present disclosure that follow the general principles of the present disclosure and include common knowledge or customary techniques in the art that are not disclosed in the present disclosure. The specification and examples are to be considered exemplary only, and the true scope and concept of the present disclosure are indicated by the claims.

Claims

1. A drug recommendation method, characterized in that: Applied to user terminals, including: In response to the operation of viewing the online test report, the test results, drug combination list and order interaction control corresponding to the online test report are displayed, the drug combination list includes drug information and drug selection controls corresponding to one or more drugs to be selected, the drugs to be selected are determined according to the test results, the user's main symptoms, user information and the user's terminal location, and the delivery time between the delivery location corresponding to the drug to be selected and the user's terminal location is less than or equal to a preset time; In response to the selection of the drug selection control, marking the selected drug among the drugs to be selected, and updating the settlement amount corresponding to the order interaction control according to the selected drug; In response to the preset operation of the order interaction control, a takeaway order corresponding to the selected medicine is generated, and a takeaway order settlement page corresponding to the takeaway order is displayed.

2. The drug recommendation method according to claim 1, characterized in that: Also includes: When the selected drugs include prescription drugs, displaying a prescription viewing entrance corresponding to the prescription drugs; In response to a triggering operation on the prescription viewing portal, the prescription is displayed.

3. The drug recommendation method according to claim 1, characterized in that: The test results, drug combination list and ordering interactive controls corresponding to the online test report include: Determine an abnormal detection index among a plurality of preset detection indexes according to the detection report; One or more drugs to be selected and the quantity of each drug to be selected are determined according to the user's main symptoms, the abnormality detection index, and the user information.

4. The drug recommendation method according to claim 3, characterized in that: Determining one or more drugs to be selected and the quantity of each drug to be selected according to the user's main symptoms, the abnormality detection index, and the user information includes: Determine one or more candidate drugs corresponding to each of the user's main symptoms and each of the abnormal detection indicators and the quantity of each of the candidate drugs; After performing a deduplication operation on the one or more candidate drugs, a candidate drug list including multiple candidate drugs is formed according to the user information; According to the ingredients of the candidate drugs in the candidate drug list, a plurality of first candidate drugs having mutually exclusive ingredients and a plurality of second candidate drugs having overlapping ingredients are determined, and the candidate drugs in the candidate drug list other than the first candidate drug and the second candidate drug are determined as third candidate drugs; Delete one or more of the first candidate drugs from the plurality of first candidate drugs based on a mutually exclusive relationship of components, and delete one or more of the second candidate drugs from the plurality of second candidate drugs based on a coincidence relationship of components; One or more drugs to be selected and the quantity of each drug to be selected are determined based on the first drug candidate, the second drug candidate, and the third drug candidate.

5. The drug recommendation method according to claim 4, characterized in that: Deleting one or more of the first candidate drugs from the plurality of first candidate drugs based on a mutually exclusive relationship of components, and deleting one or more of the second candidate drugs from the plurality of second candidate drugs based on a coincidence relationship of components includes: Determine a first priority level for each of the main complaints, wherein the main complaints of the user with a high first priority level have a high severity level; Determine a first priority of the user's main complaint symptom corresponding to each of the first candidate drugs; Among any two first candidate drugs with mutually exclusive ingredients, delete the first candidate drug with a lower first priority for the corresponding user's main complaint; Determine a second priority level of each of the anomaly detection indicators, wherein the anomaly detection indicator with a higher second priority level has a higher degree of anomaly; Determine a second priority level of the abnormality detection indicator corresponding to each of the second candidate drugs; Among any two second candidate drugs with overlapping ingredients, the second candidate drug with the lower second priority of the corresponding abnormality detection index is deleted.

6. The drug recommendation method according to claim 4, characterized in that: Forming a candidate drug list including a plurality of candidate drugs according to the user information includes: Determine the applicable age and contraindications for each candidate drug, wherein the contraindications information at least includes allergy information; Determine the user's age information and medication contraindication information according to the user information; Among the multiple alternative drugs, the alternative drugs whose applicable age does not match the age information of the user and the alternative drugs whose medication contraindications match the medication contraindications information of the user are deleted, and the alternative drug list is generated based on the remaining alternative drugs.

7. The drug recommendation method according to claim 4, characterized in that: Determining one or more of the drugs to be selected and the quantity of each of the drugs to be selected based on the first drug candidate, the second drug candidate, and the third drug candidate includes: determining at least one of the first candidate drug, the second candidate drug, and the third candidate drug corresponding to the main complaint symptom as a fourth candidate drug corresponding to the main complaint symptom; Obtaining the degree of compatibility between each of the fourth candidate drugs and the main complaint, determining the fourth candidate drug with the highest degree of compatibility as the candidate drug corresponding to the main complaint, and determining the number of the candidate drugs according to the first priority of the main complaint; determining at least one of the first candidate drug, the second candidate drug, and the third candidate drug corresponding to one of the abnormality detection indicators as a fifth candidate drug corresponding to the main complaint; Obtain the degree of compatibility between each of the fifth candidate drugs and the abnormality detection index, determine the fifth candidate drug with the highest degree of compatibility as the candidate drug corresponding to the abnormality detection index, and determine the number of the candidate drugs according to the second priority of the abnormality detection index.

8. The drug recommendation method according to claim 1, characterized in that: The test results, drug combination list and ordering interactive controls corresponding to the online test report include: Determine inventory information of multiple merchants within a preset range of the user terminal location that are in business and available for delivery and whose delivery time to the user terminal location is less than or equal to the preset time; Determine nearby merchants from among the multiple merchants whose inventory information matches the drugs to be selected in the drug combination list.

9. The drug recommendation method according to claim 8, characterized in that: The nearby merchants whose inventory information matches the drug to be selected include: Determine, based on the inventory information of the multiple merchants, one or more merchants to be selected whose inventory drugs include all of the drugs to be selected and whose quantity of the inventory drugs is greater than or equal to the quantity of the drugs to be selected; When the number of the merchants to be selected is greater than one, determining the purchase cost of medicines for each merchant to be selected based on all the medicines to be selected, and the starting price of each merchant to be selected; Deleting the candidate merchants whose drug purchase fee is lower than the minimum delivery price; Among the remaining merchants to be selected, determining the delivery fee for purchasing medicines based on all the medicines to be selected for each merchant to be selected according to the location of the user terminal; The N merchants to be selected with the smallest sum of the delivery cost and the drug purchase cost are determined as nearby merchants that can purchase the drug that matches the drug to be selected, where N≥1.

10. A computer program product, comprising a computer program, characterized in that When the computer program is executed by a processor, the steps of the method according to any one of claims 1 to 9 are implemented.

Citation Information

Patent Citations

  • Medical examination report-based medicine recommendation method and device

    CN109192266A

  • Drug purchase automatic matching method and device, electronic device and storage medium

    CN109325822A

  • medicine recommendation method and device, medium and electronic equipment

    CN109658208A

  • Resource recommendation method based on Internet of Things, and server

    CN111403043A

  • Method and system for intelligent diagnosis based on sensory perception

    CN112307345A

Cited By

  • Medicine combination information processing method and device

    CN120146952A

  • Information processing method and device, electronic equipment, storage medium and computer program product

    CN121210758A